Skip to main content

Advertisement

Log in

Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

More than a century after its first description through G.H. Whipple, the understanding of the chronic multisystemic infection called Whipple’s disease is still limited. However, within recent years the knowledge about diagnosis and treatment, the pathogenesis, and the biology of the agent itself have been improved by molecular biological and immunological methods. Despite the ubiquitous presence of the causative bacterium Tropheryma whipplei, Whipple’s disease is very rare, and immunogenetic host factors rather than the genotype of the agent influence the course of infection. Since the clinical features of classical Whipple’s disease are non-specific and the spectrum of isolated organ-specific manifestations might be underestimated, diagnosis often still is a challenge. Moreover, besides classical Whipple’s disease, there are newly recognized infections with T. whipplei, which do not fit in the concept of classical Whipple’s disease, for example, acute self-limiting infection and isolated T. whipplei endocarditis. Antibiotic therapy is usually successful. However, several problems are still unresolved, of which the most important are the following: which antibiotic should be used; how long treatment should be continued; how the immunoreconstitution inflammatory syndrome, which may occur after initiation of treatment, should be managed; and which is the best treatment of severe neurological manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Whipple GH (1907) A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 18:382–393

    CAS  Google Scholar 

  2. Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D (2008) Whipple’s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8(3):179–190

    Article  PubMed  CAS  Google Scholar 

  3. Lagier JC, Lepidi H, Raoult D, Fenollar F (2010) Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore) 89(5):337–345

    Article  Google Scholar 

  4. Raoult D, Fenollar F, Rolain JM et al (2010) Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 16(5):776–782

    PubMed  CAS  Google Scholar 

  5. Fenollar F, Trani M, Davoust B et al (2008) Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis 197(6):880–887

    Article  PubMed  CAS  Google Scholar 

  6. Schoniger-Hekele M, Petermann D, Weber B, Muller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73(6):2033–2035

    Article  PubMed  Google Scholar 

  7. Marth T, Kleen N, Stallmach A et al (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 123(5):1468–1477

    Article  PubMed  CAS  Google Scholar 

  8. Moos V, Kunkel D, Marth T et al (2006) Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol 177(3):2015–2022

    PubMed  CAS  Google Scholar 

  9. Moos V, Schmidt C, Geelhaar A et al (2010) Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology 138(1):210–220

    Article  PubMed  CAS  Google Scholar 

  10. Geelhaar A, Moos V, Schinnerling K et al (2010) Specific and nonspecific B-cell function in the small intestines of patients with Whipple’s disease. Infect Immun 78(11):4589–4592

    Article  PubMed  CAS  Google Scholar 

  11. Feurle GE, Junga NS, Marth T (2010) Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology 138(2):478–486

    Article  PubMed  CAS  Google Scholar 

  12. Fenollar F, Rolain JM, Alric L et al. (2009) Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents 34(3):255–259

    Google Scholar 

  13. Feurle GE, Marth T (1994) An evaluation of antimicrobial treatment for Whipple’s disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci 39(8):1642–1648

    Article  PubMed  CAS  Google Scholar 

  14. Panegyres PK (2008) Diagnosis and management of Whipple’s disease of the brain. Pract Neurol 8(5):311–317

    Article  PubMed  Google Scholar 

  15. Feurle GE, Moos V, Geelhaar A et al (2010) Immune reconstitution inflammatory syndrome in Whipple disease - an observational cohort study. Ann Intern Med 153:710–717

    PubMed  Google Scholar 

  16. Paulley JW (1952) A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology 22(1):128–133

    PubMed  CAS  Google Scholar 

  17. Cohen AS, Schimmel EM, Holt PR, Isselbacher KJ (1960) Ultrastructural abnormalities in Whipple’s disease. Proc Soc Exp Biol Med 105:411–414

    PubMed  CAS  Google Scholar 

  18. Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 327(5):293–301

    Article  PubMed  CAS  Google Scholar 

  19. Schoedon G, Goldenberger D, Forrer R et al (1997) Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis 176(3):672–677

    Article  PubMed  CAS  Google Scholar 

  20. Raoult D, Birg ML, La Scola B et al (2000) Cultivation of the bacillus of Whipple’s disease. N Engl J Med 342(9):620–625

    Article  PubMed  CAS  Google Scholar 

  21. La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D (2001) Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple’s disease bacillus. Int J Syst Evol Microbiol 51(Pt 4):1471–1479

    PubMed  Google Scholar 

  22. Dobbins WI (1987) Whipple’s disease. Charles C. Thomas, Springfield

    Google Scholar 

  23. Martinetti M, Biagi F, Badulli C et al. (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology 136(7):2289–2294

    Google Scholar 

  24. Boulos A, Rolain JM, Mallet MN, Raoult D (2005) Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J Antimicrob Chemother 55(2):178–181

    Article  PubMed  CAS  Google Scholar 

  25. Li W, Fenollar F, Rolain JM et al (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154(Pt 2):521–527

    Article  PubMed  CAS  Google Scholar 

  26. Bentley SD, Maiwald M, Murphy LD et al (2003) Sequencing and analysis of the genome of the Whipple’s disease bacterium Tropheryma whipplei. Lancet 361(9358):637–644

    Article  PubMed  CAS  Google Scholar 

  27. Raoult D, Ogata H, Audic S et al (2003) Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome. Genome Res 13(8):1800–1809

    PubMed  CAS  Google Scholar 

  28. Kowalczewska M, Villard C, Lafitte D, Fenollar F, Raoult D (2009) Global proteomic pattern of Tropheryma whipplei: a Whipple’s disease bacterium. Proteomics 9(6):1593–1616

    Article  PubMed  CAS  Google Scholar 

  29. Crapoulet N, Barbry P, Raoult D, Renesto P (2006) Global transcriptome analysis of Tropheryma whipplei in response to temperature stresses. J Bacteriol 188(14):5228–5239

    Article  PubMed  CAS  Google Scholar 

  30. Bonhomme CJ, Renesto P, Desnues B et al (2009) Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple’s disease. J Infect Dis 199(7):1043–1052

    Article  PubMed  CAS  Google Scholar 

  31. Raoult D, Fenollar F, Birg ML (2006) Culture of T. whipplei from the stool of a patient with Whipple’s disease. N Engl J Med 355(14):1503–1505

    Article  PubMed  CAS  Google Scholar 

  32. Rolain JM, Fenollar F, Raoult D (2007) False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol 7:48

    Article  PubMed  Google Scholar 

  33. Bousbia S, Papazian L, Auffray JP et al (2010) Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis 16(2):258–263

    PubMed  Google Scholar 

  34. Fenollar F, Mediannikov O, Socolovschi C et al (2010) Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 51(5):515–521

    Article  PubMed  Google Scholar 

  35. Fenollar F, Trape JF, Bassene H, Sokhna C, Raoult D (2009) Tropheryma whipplei in fecal samples from children, Senegal. Emerg Infect Dis 15(6):922–924

    Article  PubMed  Google Scholar 

  36. Escher R, Roth S, Droz S, Egli K, Altwegg M, Tauber MG (2010) Endocarditis due to Tropheryma whipplei: rapid detection, limited genetic diversity, and long-term clinical outcome in a local experience. Clin Microbiol Infect 16(8):1213–1222

    Article  PubMed  CAS  Google Scholar 

  37. Fenollar F, Lepidi H, Raoult D (2001) Whipple’s endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis 33(8):1309–1316

    Article  PubMed  CAS  Google Scholar 

  38. Mallmann C, Siemoneit S, Schmiedel D et al (2010) Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect 16(6):767–773

    Article  PubMed  CAS  Google Scholar 

  39. Geissdorfer W, Wittmann I, Rollinghoff M, Schoerner C, Bogdan C (2001) Detection of a new 16 S-23 S rRNA spacer sequence variant (type 7) of Tropheryma whippelii in a patient with prosthetic aortic valve endocarditis. Eur J Clin Microbiol Infect Dis 20(10):762–763

    Article  PubMed  CAS  Google Scholar 

  40. Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T (2005) Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 100(5):1167–1173

    Article  PubMed  CAS  Google Scholar 

  41. Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P (1997) Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Med Baltim 76(3):170–184

    Article  CAS  Google Scholar 

  42. Gerard A, Sarrot-Reynauld F, Liozon E et al (2002) Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Med Baltim 81(6):443–457

    Article  Google Scholar 

  43. Pruss H, Katchanov J, Zschenderlein R, Loddenkemper C, Schneider T, Moos V (2007) A patient with cerebral Whipple disease with gastric involvement but no gastrointestinal symptoms: a consequence of local protective immunity? J Neurol Neurosurg Psychiatry 78(8):896–898

    Article  PubMed  Google Scholar 

  44. von Herbay A, Maiwald M, Ditton HJ, Otto HF (1996) Histology of intestinal Whipple’s disease revisited. A study of 48 patients. Virchows Arch 429(6):335–343

    Article  Google Scholar 

  45. von Herbay A, Ditton HJ, Maiwald M (1996) Diagnostic application of a polymerase chain reaction assay for the Whipple’s disease bacterium to intestinal biopsies. Gastroenterology 110(6):1735–1743

    Article  Google Scholar 

  46. Fenollar F, Laouira S, Lepidi H, Rolain JM, Raoult D (2008) Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis 47(5):659–667

    Article  PubMed  Google Scholar 

  47. Bakkali N, Fenollar F, Biswas S, Rolain JM, Raoult D (2008) Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene. J Infect Dis 198(1):101–108

    Article  PubMed  CAS  Google Scholar 

  48. Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS (2002) Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol 118(5):742–748

    Article  PubMed  CAS  Google Scholar 

  49. Kowalczewska M, Fenollar F, Lafitte D, Raoult D (2006) Identification of candidate antigen in Whipple’s disease using a serological proteomic approach. Proteomics 6(11):3294–3305

    Article  PubMed  CAS  Google Scholar 

  50. Bonhomme CJ, Renesto P, Nandi S, Lynn AM, Raoult D (2008) Serological microarray for a paradoxical diagnostic of Whipple’s disease. Eur J Clin Microbiol Infect Dis 27(10):959–968

    Article  PubMed  CAS  Google Scholar 

  51. Fenollar F, Amphoux B, Raoult D (2009) A paradoxical Tropheryma whipplei western blot differentiates patients with Whipple disease from asymptomatic carriers. Clin Infect Dis 49(5):717–723

    Article  PubMed  CAS  Google Scholar 

  52. Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd (1985) Antibiotic treatment and relapse in Whipple’s disease. Long-term follow-up of 88 patients. Gastroenterology 88(6):1867–1873

    PubMed  CAS  Google Scholar 

  53. Lagier JC, Fenollar F, Lepidi H, Raoult D (2010) Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother 65(9):2005–2012

    Article  PubMed  CAS  Google Scholar 

  54. Cannon WR (2003) Whipple’s disease, genomics, and drug therapy. Lancet 361(9372):1916

    Article  PubMed  Google Scholar 

  55. Schneider T, Stallmach A, von Herbay A, Marth T, Strober W, Zeitz M (1998) Treatment of refractory Whipple disease with interferon-gamma. Ann Intern Med 129(11):875–877

    PubMed  CAS  Google Scholar 

  56. Lagier JC, Fenollar F, Lepidi H, Liozon E, Raoult D (2010) Successful treatment of immune reconstitution inflammatory syndrome in Whipple’s disease using thalidomide. J Infect 60(1):79–82

    Article  PubMed  Google Scholar 

  57. Pauletti C, Pujia F, Accorinti M et al (2010) An atypical case of neuro-Whipple: Clinical presentation, magnetic resonance spectroscopy and follow-up. J Neurol Sci 297(1–2):97–100

    Article  PubMed  Google Scholar 

  58. Panegyres PK, Edis R, Beaman M, Fallon M (2006) Primary Whipple’s disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM 99(9):609–623

    Article  PubMed  CAS  Google Scholar 

  59. Thwaites GE, Nguyen DB, Nguyen HD et al (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351(17):1741–1751

    Article  PubMed  CAS  Google Scholar 

  60. Raoult D, Lepidi H, Harle JR (2001) Tropheryma whipplei circulating in blood monocytes. N Engl J Med 345(7):548

    Article  PubMed  CAS  Google Scholar 

  61. Kalt A, Schneider T, Ring S et al (2006) Decreased levels of interleukin-12p40 in the serum of patients with Whipple’s disease. Int J Colorectal Dis 21(2):114–120

    Article  PubMed  CAS  Google Scholar 

  62. Al Moussawi K, Ghigo E, Kalinke U, Alexopoulou L, Mege JL, Desnues B (2010) Type I interferon induction is detrimental during infection with the Whipple’s disease bacterium, Tropheryma whipplei. PLoS Pathog 6(1):e1000722

    Article  PubMed  Google Scholar 

  63. Desnues B, Raoult D, Mege JL (2005) IL-16 is critical for Tropheryma whipplei replication in Whipple’s disease. J Immunol 175(7):4575–4582

    PubMed  CAS  Google Scholar 

  64. Ghigo E, Barry AO, Pretat L et al (2010) IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS ONE 5(10):e13561

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by EU Contract No. QLG1-CT-2002-01049 and the Deutsche Forschungs Gemeinschaft KFO 104 and SFB 633.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Moos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moos, V., Schneider, T. Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei . Eur J Clin Microbiol Infect Dis 30, 1151–1158 (2011). https://doi.org/10.1007/s10096-011-1209-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1209-y

Keywords

Navigation